Interpace Announces Extension of LabCorp Agreement
24 févr. 2020 06h55 HE
|
Interpace Biosciences, Inc.
ThyGeNEXT and ThyraMIR Collaboration Extended for Another Two Years PARSIPPANY, NJ, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) announced today that its...
DiamiR Announces Presentation at Extracellular Biomarkers Summit 2015
11 mars 2015 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 11, 2015) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...